2 novembre 2024
Linkedin Twitter

covid-moderate

NIH clinical trial to test antibodies and other experimental therapeutics for mild and moderate COVID-19

sanofi gsk covid
Risk
RIS.WORLD
RIS.WORLD est le Magazine Réglementaire des Industries de Santé
Contactez-nous: contact@ris.world
Linkedin Twitter
© 2023 - RIS.WORLD By WHITE-TILLET